DNM2 and cancer: Bourguignon et al. [46] demonstrated that HA activation of RhoA-PLCE1 stimulates intracellular Ca2+ mobilization and Ca2+/calmodulin-dependent kinase II, leading to phosphorylation of the cytoskeletal protein and filamin and promotion of cancer cell migration in human head and neck squamous carcinoma.